Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07163988 · ClinicalTrials.gov registry record
Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 312
- Enrollment target
NCT07163988: Completed study, sponsored by Rohan Dharmakumar.
NCT07163988 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 312 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07163988 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
Study Summary
TROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI classification. The study retrospectively analyzes biomarker data from patients diagnosed with AMI across multiple institutions, focusing on whether hs-cTnI levels-measured at specific time points-can reliably identify and stratify patients into AMI clinical stages (Stage 1 to Stage 4). It aims to correlate hs-cTnI kinetics and peak levels with clinical stage, presentation patterns, and outcomes. This trial seeks to offer a biomarker-based alternative to imaging-heavy staging, potentially streamlining early diagnosis and therapeutic triage for AMI patients in varied clinical settings.
Primary Outcome
Levels of hs-cTn-I to differentiate AMI Stages I-IV (Classified by CMR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2025-09-30 |
What the finished NCT07163988 record still lists
NCT07163988 is an observational study that tracks outcomes without assigning an intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07163988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07163988 about?
NCT07163988 is a clinical study titled "Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I". TROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI classification. The...
What is the current status of trial NCT07163988?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2023-01-10. Estimated completion is 2025-09-30.
Who is sponsoring clinical trial NCT07163988?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI